Biohaven Ltd.
BHVN· NYSE
Filed Jul 31, 2023 · 10-Q · 31 days after period end · 0001935979-23-000052
| Metric | Q2 2023 | Q2 2022 | Q2 2021 |
|---|---|---|---|
| Net Income | -$90.35M | -$203.29M | -$45.42M |
| EPS Diluted | -$1.32 | -$5.16 | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Biohaven Ltd. · CIK 1935979 · Engraved from SEC EDGAR
ended Jun 30, 2023 · filed Jul 31, 2023 · 31 d after period end